FEDERAL DISTRICT GOVERNMENT - GDF has floated a tender for Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula Dura 75 Mg and Others, According to Specifications and Quantities Contained in Annex i of the Notice.. The project location is Brazil and the tender is closing on 19 Mar 2024. The tender notice number is 90027/2024, while the TOT Ref Number is 98412726. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Brazil

Summary : Process for Potential Purchase/Contracting of Dabrafenibe (Mesylate) Capsula Dura 75 Mg and Others, According to Specifications and Quantities Contained in Annex i of the Notice.

Deadline : 19 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98412726

Document Ref. No. : 90027/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Object: Electronic Auction - Process for potential purchase/contracting of DABRAFENIBE (MESYLATE) CAPSULA DURA 75 MG and others, according to specifications and quantities contained in Annex I of the Notice.

UASG Code: 926119

Notice as of: 07/03/ 2024 from 08:00 to 12:00 and from 13:00 to 17:0019981d172c851bd4e8a1788d5726c2d3

Proposal Delivery: from 03/07/2024 at 08:00

DABRAFENIB, CONCENTRATION 75 MG

Quantity: 3240

DABRAFENIB, CONCENTRATION 75 MG

Quantity: 1080

FLUNITRAZEPAM, DOSAGE 1 MG

Quantity: 3240

MEDICAL ExTRACT, ACTIVE INGREDIENT GLYCINE MAx (L.) MERRIL, CONCENTRATION 150 MG

Quantity: 216019981d172c851bd4e8a1788d5726c2d3

HYDROxIZINE HYDROCHLORIDE, DOSAGE 25 MG

Quantity: 2160

INSULIN, ASPART ORIGIN, CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE WITH APPLICATOR

Quantity: 108

LENVATINIB, CONCENTRATION 4 MG

Quantity: 1620

LENVATINIB, CONCENTRATION 4 MG

Quantity: 540

LEV19981d172c851bd4e8a1788d5726c2d3ODOPA, COMPOSITION ASSOCIATED WITH BENSERAZIDE, DOSAGE 100MG 25MG, PRESENTATION DISPERSIBLE TABLETS

Quantity: 10800

NUSINERSENE, CONCENTRATION 2.4 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 27

NUSINERSENE, CONCENTRATION 2.4 MG/ML, FOR MA PHARMACEUTICAL INJECTABLE SOLUTION

Quantity: 919981d172c851bd4e8a1788d5726c2d3

ORLISTATE, DOSAGE 120 MG

Quantity: 2160

Documents

 Tender Notice